Pharmafile Logo
Pharmafocus logo
Advanced Search

Benlysta

Showing 5 posts of 20 posts found.

Benlysta to be fast-tracked by FDA

August 20, 2010
Sales and Marketing Benlysta, GSK, HGS, Lupus

 New lupus drug Benlysta has been given priority review status by the FDA.Benlysta (belimumab) has been developed by Human Genome …

News

UCB’s new lupus treatment promising

June 17, 2010
Research and Development Benlysta, Lupus, UCB, epratuzumab

A new monoclonal antibody treatment for lupus has shown promise in phase II trials, according to UCB. The biopharmaceutical company …

News

EU regulators to assess potential lupus breakthrough drug

June 8, 2010
Sales and Marketing Benlysta, Human Genome Sciences, Lupus

GlaxoSmithKline and Human Genome Sciences have submitted a marketing application to the European Medicines Agency for their new lupus drug. …

News

Phase III success for GSK’s lupus drug

November 3, 2009
Research and Development, Sales and Marketing Benlysta, GSK

 GlaxoSmithKline’s lupus drug Benlysta has been successful in the second of two phase III trials, following earlier performance that exceeded …

News

Lupus drug shows surprise phase III success

July 23, 2009
Research and Development, Sales and Marketing Benlysta, GSK, HGS, Lupus

 GSK and Human Genome Sciences’ lupus drug Benlysta has surprised analysts by showing unexpectedly positive results in a pivotal late-stage …

News
The Gateway to Local Adoption Series

Latest content

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026